MEG3 is upregulated in esophageal squamous cell carcinoma, colorectal cancer, hepatocellular carcinoma, and gastric cancer and, therefore, promotes tumor progression [54, 55]. This evidence concerns the gene MEG3 and hepatocellular carcinoma.